ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC34.02

C34.02

Billable

Malignant neoplasm of left main bronchus

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C34.02 is a billable code used to indicate a diagnosis of malignant neoplasm of left main bronchus.

Key Diagnostic Point:

C34.02 refers to a malignant neoplasm located in the left main bronchus, which is a critical airway structure that branches from the trachea into the left lung. This type of lung cancer is often associated with significant morbidity and mortality, primarily due to its aggressive nature and late presentation. Risk factors include a history of smoking, exposure to secondhand smoke, occupational hazards, and environmental pollutants. The staging of lung cancer, particularly for bronchial tumors, follows the TNM classification system, which assesses tumor size (T), lymph node involvement (N), and distant metastasis (M). Molecular markers such as EGFR mutations, ALK rearrangements, and PD-L1 expression are increasingly important for targeted therapies and immunotherapy options. Treatment algorithms typically involve a multidisciplinary approach, including surgery, chemotherapy, radiation therapy, and targeted therapies, depending on the stage and specific characteristics of the tumor. Early detection and intervention are crucial for improving outcomes in patients diagnosed with this condition.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Need for accurate staging based on TNM classification
  • Variability in treatment protocols based on molecular markers
  • Documentation of smoking history and other risk factors
  • Differentiation from other lung cancer types

Audit Risk Factors

  • Inadequate documentation of smoking history
  • Failure to document staging details
  • Misclassification of tumor type or location
  • Lack of clarity on treatment plans

Specialty Focus

Medical Specialties

Oncology

Documentation Requirements

Detailed pathology reports, imaging studies, and treatment plans must be documented.

Common Clinical Scenarios

Patients presenting with cough, hemoptysis, or unexplained weight loss.

Billing Considerations

Ensure all relevant molecular testing results are included in the documentation.

Pulmonology

Documentation Requirements

Pulmonary function tests, imaging results, and smoking history must be documented.

Common Clinical Scenarios

Patients with chronic cough and a history of smoking presenting for evaluation.

Billing Considerations

Document any comorbid respiratory conditions that may affect treatment.

Coding Guidelines

Inclusion Criteria

Use C34.02 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the primary site, staging, and any associated conditions
  • Include details on the patient's smoking history and any relevant molecular testing

Exclusion Criteria

Do NOT use C34.02 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

31622CPT Code

Bronchoscopy, rigid or flexible

Clinical Scenario

Used for diagnosis and staging of lung cancer.

Documentation Requirements

Document indications for bronchoscopy and findings.

Specialty Considerations

Pulmonology specialists should ensure thorough documentation of the procedure.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of lung cancers, including the ability to differentiate between left and right main bronchus malignancies, which aids in treatment planning and research.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of lung cancers, including the ability to differentiate between left and right main bronchus malignancies, which aids in treatment planning and research.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of lung cancers, including the ability to differentiate between left and right main bronchus malignancies, which aids in treatment planning and research.

Resources

Clinical References

  • •
    American Cancer Society - Lung Cancer

Coding & Billing References

  • •
    American Cancer Society - Lung Cancer

Frequently Asked Questions

What is the primary risk factor for C34.02?

The primary risk factor for malignant neoplasm of the left main bronchus is a history of smoking, along with exposure to environmental toxins and genetic predispositions.